Search
Amicus Therapeutics Inc
FOLDAdd to Watchlist
14.490USD
0.0000.00%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
4.55BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-04-24The current earnings forecast score of Amicus Therapeutics Inc is 6.25, ranking 334 out of 389 in the Biotechnology & Medical Research industry. The average price target is 16.00, with a high of 22.00 and a low of 11.00.
No Data
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Amicus Therapeutics Inc's expected revenue for the next quarter?
Amicus Therapeutics Inc's expected revenue is 159.29M.
What is Amicus Therapeutics Inc's price target?
Analysts forecast that Amicus Therapeutics Inc's price target is USD 16.00, with the highest forecast at USD 22.00 and the lowest forecast at USD 11.00.
How have Amicus Therapeutics IncFOLD's recent earnings per share performed?
The market expectation was USD 0.01, while Amicus Therapeutics IncFOLD's earnings per share (EPS) for the previous quarter was USD 0.06. EPS for the next quarter is expected at USD 0.04.
